BACKGROUND. Rhabdomyosarcoma (RMS) in adults (age greater than or equal to
16 years) is rare, accounting for less than 3% of adult soft tissue sarcoma
s. There is little information describing the disease biology or clinicopat
hologic factors that influence survival in adults with RMS. The objective o
f this study was to define the factors in patients with adult RMS that pred
ict outcome, disease progression, and survival.
METHODS. Eighty-four adult patients with a pathologic diagnosis of RMS that
was confirmed by immunohistochemistry were identified by a prospective inp
atient data base during the period 1982-1999 and were analyzed for disease
specific survival and metastasis free survival using the Kaplan-Meier actua
rial method. Statistical significance was evaluated using the log-rank test
for univariate influence and a Cox regression model for multivariate influ
ence.
RESULTS. The median disease specific survival was 22 months. Patient age, e
xtent of disease, tumor size at the time of diagnosis, and margin status af
ter resection were significant predictors of disease specific survival. Pat
ients who underwent a complete resection had a significantly longer median
survival (105 months) compared with any other subgroup of patients. The his
tologic subtype did not predict patient survival but did vary with patient
age. Most notably, the proportion of the pleomorphic subtype increased with
advancing age, accounting for 42% of RMS in patients over the age of 40 pa
rs.
CONCLUSIONS. The most important predictors of outcome in patients with adul
t RMS are patient age, tumor size, extent of disease, and margin status aft
er resection. In contrast to patients with pediatric RMS, no association wa
s noted between survival and histologic subtype in this group of patients w
ith adult RMS. All histologic subtypes of RMS are aggressive malignancies w
ith poor disease specific survival despite aggressive multimodality managem
ent. (C) 2001 American Cancer Society.